Work

Activity of Triciribine and Triciribine-5′ -Monophosphate Against Human Immunodeficiency Virus Types 1 and 2

Year: 1993

Type: article

Source: AIDS Research and Human Retroviruses

DOI: 10.1089/aid.1993.9.307

Authors: Louis S. Kucera, Nathan P. Iyer, Shelby H. Puckett, Robert W. Buckheit, Louise Westbrook, Barbara R. Toyer, E. Lucile White, Julie M. Germany-Decker, William M. Shannon, Robert C.-S. Chen, M. Reza Nassiri, Charles Shipman, Leroy B. Townsend, John C. Drach

Institutions: Wake Forest University Health Sciences, Wake Forest University, University of Michigan

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Wake Forest University, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G1026282098, G171801271, G3608580336, DRUGS TO TREAT HUMAN CYTOMEGALOVIRUS INFECTIONS, NUCLEOSIDES &THIOSEMICARBAZONES AS SELECTIVE INHIBITORS, Cancer Center Support Grant

OpenAlex ID: W2062750943

FWCI:

Cites: 14

Cited by: 16

Related to: 10